Sign In
Buy ZOM
$0.0973
+0 (+0%)
At Close: Jun 03, 2025
Zomedica Corp. Announces Transition to OTCQB Venture Market
05:30pm, Tuesday, 04'th Mar 2025
Zomedica's ticker symbol will change to ZOMDF ANN ARBOR, MI / ACCESS Newswire / March 4, 2025 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a leading veterinary health company of
NYSE American to Commence Delisting Proceedings Against Zomedica Corp. (ZOM)
04:15pm, Tuesday, 04'th Mar 2025
NEW YORK--(BUSINESS WIRE)--NYSE American LLC (“NYSE American” or the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the common s
Zomedica to Report Fourth Quarter and Full Year 2024 Financial Results with a Business Update on March 13th at 4:30 p.m. ET
06:30am, Wednesday, 26'th Feb 2025
ANN ARBOR, MI / ACCESS Newswire / February 26, 2025 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic pr
Zomedica Improves Efficiency and Cuts Costs by Moving to New Headquarters
06:30am, Wednesday, 12'th Feb 2025
Relocation to More Efficient Space Supports Growth While Reducing Overhead by Over $200,000 Annually ANN ARBOR, MI / ACCESS Newswire / February 12, 2025 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica
Zomedica Launches the TRUFORMA(R) Enhanced Endogenous ACTH Assay to aid in Equine PPID Diagnosis
06:30am, Thursday, 06'th Feb 2025
Zomedica continues to redefine what is possible in point of care diagnostics with the TRUFORMA biosensor platform ANN ARBOR, MI / ACCESS Newswire / February 6, 2025 / Zomedica Corp. (NYSE American:ZOM
License Agreement Expands Zomedica's Portfolio with Revolutionary Hemostatic Technology ANN ARBOR, MI / ACCESSWIRE / January 7, 2025 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"),
Zomedica Launches Two New Quantitative Assays on the TRUFORMA(R) Platform: Canine NT-proBNP and Progesterone
06:30am, Monday, 23'rd Dec 2024
With the addition of these two new assay launches, Zomedica has added 8 new assays in the past 18 months to the rapidly growing TRUFORMA Platform ANN ARBOR, MI / ACCESSWIRE / December 23, 2024 / Zomed
Zomedica Appoints Scott A. Jordan Executive Vice President, Finance & Chief Financial Officer
06:30am, Thursday, 19'th Dec 2024
Seasoned executive brings a broad skill set to Zomedica's leadership team ANN ARBOR, MI / ACCESSWIRE / December 19, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinar
Zomedica to Present at the NobleCon20 Twentieth Annual Emerging Growth Equity Conference December 4, 2024
06:30am, Wednesday, 27'th Nov 2024
ANN ARBOR, MI / ACCESSWIRE / November 27, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic produc
Zomedica Launches Quantitative Insulin Assay for Equine Plasma on the TRUFORMA(R) Platform
06:30am, Thursday, 14'th Nov 2024
Combined with Zomedica's eACTH assay, equine veterinarians get same day answers for their PPID and EMS patients ANN ARBOR, MI / ACCESSWIRE / November 14, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zo
Noble Capital Markets Initiates Equity Research Coverage on Zomedica
06:30am, Tuesday, 12'th Nov 2024
ANN ARBOR, MI / ACCESSWIRE / November 12, 2024 / Zomedica Corp. (NYSE American:ZOM), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion an
Zomedica to Present at the Sidoti Micro Cap Conference November 14, 2024
06:30am, Friday, 08'th Nov 2024
ANN ARBOR, MI / ACCESSWIRE / November 8, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic product
Zomedica Corp. (ZOM) Q3 2024 Earnings Call Transcript
08:43pm, Thursday, 07'th Nov 2024
Zomedica Corp. (NYSE:ZOM ) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET Company Participants Larry Heaton – Chief Executive Officer Mike Zuehlke – Vice President and Corporate Cont
ANN ARBOR, MI / ACCESSWIRE / November 7, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products
Zomedica Launches Ear Cytology Quick Scan Protocol for TRUVIEW(TM) Digital Microscope & Telepathology Platform
06:30am, Thursday, 24'th Oct 2024
New Ear Cytology protocol significantly improves veterinary practice workflow by reducing total time to perform common diagnostic procedure ANN ARBOR, MI / ACCESSWIRE / October 24, 2024 / Zomedica Cor
